These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3982601)

  • 1. Cocaine and phencyclidine. Heterogenous dopaminergic interactions with tetrabenazine.
    Bagchi SP
    Neuropharmacology; 1985 Jan; 24(1):37-41. PubMed ID: 3982601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential interactions of phencyclidine with tetrabenazine and reserpine affecting intraneuronal dopamine.
    Bagchi SP
    Biochem Pharmacol; 1983 Oct; 32(19):2851-6. PubMed ID: 6626259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergent reserpine effects on amfonelic acid and amphetamine stimulation of synaptosomal dopamine formation from phenylalanine.
    Bagchi SP; Smith TM; Bagchi P
    Biochem Pharmacol; 1980 Nov; 29(21):2957-62. PubMed ID: 6109534
    [No Abstract]   [Full Text] [Related]  

  • 4. Intraneuronal dopaminergic action of cocaine and some of its metabolites and analogs.
    Bagchi SP; Reilly MA
    Neuropharmacology; 1983 Nov; 22(11):1289-95. PubMed ID: 6664461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of phencyclidine on synaptosomal dopamine continuously appearing from phenylalanine: sensitivity to reserpine.
    Bagchi SP
    Neuropharmacology; 1981 Sep; 20(9):845-51. PubMed ID: 7290357
    [No Abstract]   [Full Text] [Related]  

  • 6. Actions of amfonelic acid and other non-amphetamine stimulants on the dopamine neuron.
    Shore PA
    J Pharm Pharmacol; 1976 Nov; 28(11):855-7. PubMed ID: 11304
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of CNS stimulants with phencyclidine on dopamine release using in vivo voltammetry.
    Howard-Butcher S; Blaha CD; Lane RF
    Brain Res Bull; 1984 Oct; 13(4):497-501. PubMed ID: 6151866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of reserpine and tetrabenazine on rat striatal synaptosomal dopamine biosynthesis and synaptosomal dopamine pools.
    Kuczenski R
    J Pharmacol Exp Ther; 1977 May; 201(2):357-67. PubMed ID: 870679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the acute actions of amine-depleting drugs and dopamine receptor antagonists on dopamine function in the brain in rats.
    Hong M; Jenner P; Marsden CD
    Neuropharmacology; 1987; 26(2-3):237-45. PubMed ID: 2884588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of phencyclidine, amphetamine and related compounds on dopamine release from and uptake into striatal synaptosomes.
    Bowyer JF; Spuhler KP; Weiner N
    J Pharmacol Exp Ther; 1984 Jun; 229(3):671-80. PubMed ID: 6726652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of synaptosomal dopamine formed from tyrosine and L-DOPA.
    Bagchi SP; Bagchi P; Smith TM
    Brain Res; 1980 Apr; 187(2):403-14. PubMed ID: 7370738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of synaptosomal tyrosine hydroxylation by phencyclidine in vitro.
    Vickroy TW; Johnson KM
    Eur J Pharmacol; 1981 May; 71(4):463-73. PubMed ID: 7250199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synaptosomal dopamine from phenylalanine in brain: effects of some dopaminergic agents.
    Bagchi SP; Smith TM
    Res Commun Chem Pathol Pharmacol; 1979 Dec; 26(3):447-58. PubMed ID: 523781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similar dopamine-releasing effects of phencyclidine and nonamphetamine stimulants in striatal slices.
    Vickroy TW; Johnson KM
    J Pharmacol Exp Ther; 1982 Dec; 223(3):669-74. PubMed ID: 6128403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biochemical characterization and differentiation of dopaminergic supersensitivity in the rat].
    Funk KF; Schmidt J; Westermann KH
    Biomed Biochim Acta; 1986; 45(3):393-9. PubMed ID: 3707556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of reserpine on extracellular caudate dopamine and hippocampus norepinephrine responses to amphetamine and cocaine: mechanistic and behavioral considerations.
    Florin SM; Kuczenski R; Segal DS
    J Pharmacol Exp Ther; 1995 Jul; 274(1):231-41. PubMed ID: 7616403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine evidence that tetrabenazine is a dopamine antagonist.
    Login IS; Cronin MJ; Harcus CT; MacLeod RM
    Proc Soc Exp Biol Med; 1983 Feb; 172(2):225-31. PubMed ID: 6828467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetrabenazine, an amine-depleting drug, also blocks dopamine receptors in rat brain.
    Reches A; Burke RE; Kuhn CM; Hassan MN; Jackson VR; Fahn S
    J Pharmacol Exp Ther; 1983 Jun; 225(3):515-21. PubMed ID: 6864517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats.
    Carboni E; Imperato A; Perezzani L; Di Chiara G
    Neuroscience; 1989; 28(3):653-61. PubMed ID: 2710338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of responses by neuropeptide systems in rat to the psychotropic drugs, methamphetamine, cocaine and PCP.
    Hanson GR; Midgley LP; Bush LG; Johnson M; Gibb JW
    NIDA Res Monogr; 1989; 95():348. PubMed ID: 2484267
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.